|

[68Ga]Ga-FAPI-46 Clinical Trials

3 actively recruiting trials

▲ +2 trials since June 2026

Also known as: [68Ga]FAPI-46

Pipeline

Phase 2: 3

Top Sponsors

  • Barbara Malene Fischer2
  • Universität Münster1

Indications

  • Cancer3
  • Carcinoma, Intraductal, Noninfiltrating1
  • Malignant Melanoma Stage IV1
  • Gastroesophageal Cancer (GC)1
  • Pancreatic Cancer, Adult1

Other3 trials

BEFAST Study, [68Ga]Ga-FAPI Total Body PET/CT for Better and Faster Imaging in Cancer
Phase 2
Multimodal Imaging With FAPI-PET/MRI in Breast Carcinoma-In-Situ for Detection of Occult Invasive Cancer
Phase 2
[68Ga]Ga-FAPI Total Body PET/CT for Better and Faster Imaging in Cancer
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.